Institute

Researchers in Southampton have found that a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

Today, we’ve announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx. 

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

A long-term study funded by Cancer Research UK has revealed how air pollution can cause lung cancer in people who have never smoked. 

We dive into five innovations from the world’s greatest minds that could transform the way we deal with cancer

If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that. 

Dr Hugo De La Peña, the face of our latest TV advert, explains how a second chance at life led to a career dedicated to curing cancer.  

Our scientists across the country are working hard to tackle drug resistance – one of cancer’s cruellest curveballs.

Vivian Li, group leader of the stem cell and cancer biology lab at the Francis Crick Institute, talks tumours and how she aims to target them.

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.